Stock·NASDAQ·Energy
Baker Hughes Company (BKR)
- Market cap
- $55.29B
- P/E
- 17.49
- Dividend yield
- 1.65%
- Street target
- $73.00median of 25 analysts
- 52-week range
- $44.26 $70.41
The short version
Where BKR stands today, in four lines, and what CleaRank Financial AI makes of it.
BKR at a glance
Baker Hughes Company (BKR): Hold, 49/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($59.79 and $59.90).
- Earnings BKR beat estimates in 8 of its last 8 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $103.2M and made no open-market purchases over the last 18 months.
- Valuation P/E of 17.5 against 18.4 for the Energy sector: broadly in line with peers (-5%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Baker Hughes Company (BKR) Hold, with a model score of 49/100.
The analysts' outlook lifts the score most: 20 of 25 analysts rate it a buy and the median target is 31.1% above the price. The trend holds it back most: the price is 7.01% below its 200-day average and 6.85% below its 50-day average, and the 50-day average is 0.17% below the 200-day. The 50-day average stands at $59.79 and the 200-day at $59.90. Over the past year the price rose 24.78%.
Only on CleaRank
Figures we compute ourselves from BKR's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $55.70 is 6.8% below the 50-day simple moving average of $59.79.Price above its 200-day average ›
The price is 7.0% below the 200-day simple moving average of $59.90.50-day average above the 200-day ›
The 50-day average ($59.79) is 0.2% below the 200-day average ($59.90), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 44% of its 52-week range, between $44.26 and $70.41.
BKR share price
Pick a period: each tab shows how far BKR has moved over it, to the last close.
Today's trading
Where BKR sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 17.49 is 4.9% below the Energy median of 18.4.P/S below the sector median ›
The price-to-sales ratio of 1.95 is 22.1% below the sector median of 2.5.Profitable over the last 12 months ›
Net income over the last 12 months was $3.1B on revenue of $27.7B, a net margin of 11.2%.Beat estimates in most recent reports ›
BKR beat the EPS estimate in 8 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.65%, or $0.92 a share a year.
Key statistics
The headline figures for BKR.
As of October 17, 2026, BKR trades at $55.70, with a market value of $55.29B, a P/E ratio of 17.49 and a dividend yield of 1.65%.
What the numbers say
CleaRank Financial AI's reading of BKR's valuation, growth and risks.
On earnings, Baker Hughes Company (BKR) is valued at 17.49 times, against a median of 18.4 for Energy: broadly in line with peers, with the P/E 4.9% below that median. On sales, the P/S of 1.95 compares with a sector median of 2.5, 22.0% below it. The company has trailing earnings of $3.11 a share.
In the latest year revenue fell 2.40%, 35.2 percentage points slower than the sector median of 32.8%. Margins stand at a net margin of 11.17% and an operating margin of 12.83%. It reports a return on equity of 16.46%, above the sector median of 14.2%. Debt-to-equity of 0.81 and a trailing dividend yield of 1.65% ($0.92 a share a year) round out the fundamentals.
Baker Hughes Company (BKR) beat expectations in its July 26, 2026 report by 30.61%, with $0.64 a share against a $0.49 estimate. Even so, the stock fell 3.52% in the next session.
Across its last 8 reports, BKR beat the estimate every time, though the stock still fell in the first session after 4 of those 8 beats. The July 22, 2025 report stands out among the earlier ones: a beat of 14.55%, after which the stock rose 11.64%. Looking ahead, analysts expect EPS of $2.59 this fiscal year (a decline of 0.5%) and $2.96 the year after (growth of 14.3%).
BKR typically swings about 1.92% a day. The downtrend adds risk for as long as the price stays under both moving averages. The price is 20.89% below its 52-week high of $70.41. Insiders sold $103.2M of stock over the last 18 months and bought none on the open market. Sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market buying.
BKR against the Energy sector
How BKR compares with the median Energy stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-5% difference), suggesting fair market pricing relative to industry standards.
Return vs XLE: Since May 6, 2025, BKR has gained 53.0% against a gain of 69.5% for XLE.
Performance against XLE
BKR and the Energy sector fund over the same days.
Revenue and earnings
How much BKR sells, and how much of it becomes profit.
Revenue growth: Revenue fell 0.3% in FY2025 to $27.7B, from $27.8B a year earlier.
Profit margin: The net margin was 9.5% in FY2025, down from 10.8% the year before.
Profitable: BKR earned $2.6B in FY2025.
Earnings reality check
Did BKR beat what analysts expected, and how did the stock react?
Earnings record: BKR beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 4 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 26, 2026after close | $0.49 | $0.64 | +30.61% | -3.52% | +0.36% |
| Apr 23, 2026after close | $0.49 | $0.58 | +18.37% | +6.90% | +8.03% |
| Oct 23, 2025after close | $0.62 | $0.68 | +9.68% | -3.25% | -0.63% |
| Jul 22, 2025after close | $0.55 | $0.63 | +14.55% | +11.64% | +14.32% |
| Apr 22, 2025after close | $0.47 | $0.51 | +8.51% | -6.44% | -6.36% |
| Jan 30, 2025after close | $0.63 | $0.70 | +11.11% | +3.54% | +5.34% |
| Oct 22, 2024after close | $0.61 | $0.67 | +9.84% | +2.83% | +3.09% |
| Jul 25, 2024after close | $0.49 | $0.57 | +16.33% | -0.37% | -0.34% |
As of October 17, 2026, BKR has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on July 26, 2026, came in 30.61% above the estimate and the stock moved -3.52% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 43.2, in neutral territory.RSI above 50 ›
An RSI of 43.2 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of BKR
The score, the reasoning behind it, and what could move the price next.
Baker Hughes Company (BKR) is in a downtrend: both moving averages sit above the price. At $55.70, the stock is 6.85% below its 50-day average of $59.79 and 7.01% below its 200-day average of $59.90. The two averages point the same way, with the 50-day 0.17% below the 200-day. Across the 52-week range, from $44.26 to $70.41, the price sits at 44% of the way up.
A recent pullback sits inside a stronger longer record: the price fell 1.10% over the past month, fell 0.45% over the past three months and rose 24.78% over the past year. On momentum, the 14-day RSI reads 43.2, in the neutral zone, with the MACD line negative.
Earnings beat ›
The July 26, 2026 report beat the EPS estimate by 30.61%, and the share price fell 3.52% in the first session after it.
Source: Earnings report, July 26, 2026
Rating reaffirmed ›
UBS kept its Neutral rating on September 30, 2026.
Source: Analyst action, UBS, September 30, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $56.64 sits above the price, and the 52-week low at $44.26 sits below it.
- The 14-day RSI is 43.2, which is neutral, and the MACD line is negative. Readings above 70 or below 30 signal stretched momentum.
- The share price fell 3.52% in the first session after the July 26, 2026 report, even though BKR beat estimates in 8 of its last 8 reports.
The downtrend stays in place while BKR is below both its 50-day average at $59.79 and its 200-day average at $59.90; a close back above the 50-day would be the first step of a repair. The 20-day EMA at $56.64 is the first hurdle overhead.
The next level below the price is the 52-week low at $44.26.
Technical indicators
Momentum and trend for BKR, from its daily closes.
As of October 17, 2026, with BKR at $55.70, its 14-day RSI is 43.2 (neutral territory), its 50-day simple moving average is $59.79 and its 200-day is $59.90.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What BKR moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, BKR's 1-year correlation of daily returns is +0.48 with S&P 500 (SPY), +0.42 with Nasdaq 100 (QQQ), +0.09 with Bitcoin (BTC) and +0.16 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
20 of 25 analysts rate it a buy or strong buy, 4 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $73.00 is 31.1% above the price.More buy ratings than three months ago ›
20 of 25 rate it a buy now, against 18 of 23 three months ago.
BKR Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 30, 2026 | UBS | Maintains | Neutral |
| Sep 29, 2026 | Jefferies | Maintains | Buy |
| Sep 29, 2026 | Goldman Sachs | Reinstates | Buy |
| Sep 14, 2026 | UBS | Maintains | Neutral |
| Sep 10, 2026 | Susquehanna | Maintains | Positive |
| Sep 10, 2026 | UBS | Maintains | Neutral |
As of October 17, 2026, 25 Wall Street analysts cover BKR: 20 rate it a buy or strong buy, 4 a hold and 1 a sell or strong sell. Their 12-month price targets range from $51.00 to $85.00, with a median of $73.00, 31.1% above the price of $55.70.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
BKR trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from BKR's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much BKR tends to move, against the market and on its own.
The long record
BKR's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.92% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 75.9%, from December 2016 to March 2020, regained by July 2024.Most 1-year holds ended higher ›
61% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $20,548, against $42,055 in the S&P 500 (SPY).
BKR Drawdowns & Recovery
As of October 17, 2026, BKR's worst peak-to-trough fall over the last 10 years with dividends reinvested was -75.9% (December 2016 to March 2020); it regained that peak by July 2024, 52 months after the low, and 61% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into BKR in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: BKR trailed the S&P 500 over this period: $20,548 against $42,055.
A $10,000 investment in BKR in October 2016 would be worth about $20,548 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to BKR, and which have not.
Strongest month, November: an average of +5.76%, up in 6 of 10 years.
Weakest month, March: an average of -1.17%, up in 5 of 10 years.
This month, October: has averaged -0.35%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, BKR's strongest calendar month has been November (average +5.76%, up in 6 of 10 years) and its weakest March (average -1.17%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in BKR, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BKR today could grow to about $14,214 by 2036 in the base case, with a 90th-percentile outcome near $76,204 and a 10th-percentile outcome around $2,651. The simulation models price only; at today's 1.65% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
BKR Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $64.11 for BKR by 2030 in the base case, from $55.70 today (1.2x over 4 years). The 10th-percentile path ends near $22.17. These are outcomes of a Monte Carlo simulation run on BKR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $33.92 | $57.69 | $98.12 | |
| 2028 | $28.20 | $59.76 | $127 | |
| 2029 | $24.67 | $61.90 | $155 | |
| 2030 | $22.17 | $64.11 | $185 | |
| 2031 | $20.26 | $66.41 | $218 |
Method: a lognormal simulation of BKR's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
BKR insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought BKR shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, BKR insiders reported 27 open-market sales worth $103.2M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Amerino Gatti
Officer
|
Grant | 9.8K | - |
| Jul 1, 2026 | Maria Claudia Borras
Officer
|
Sell | 72.0K | $4.0M |
| Jun 22, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Sell | 181.4K | $10.6M |
| Jun 22, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Option | 99.9K | $3.6M |
| Jun 15, 2026 | Ahmed Farhan Moghal
Chief Financial Officer
|
Sell | 23.4K | $1.5M |
| Jun 12, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Sell | 181.4K | $11.5M |
| Jun 12, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Option | 99.9K | $3.6M |
| Jun 3, 2026 | Rebecca L Charlton
Officer
|
Sell | 5.1K | $326.8K |
| Jun 1, 2026 | Rebecca L Charlton
Officer
|
Grant | 11.7K | - |
| May 19, 2026 | James E Apostolides
Officer
|
Sell | 12.3K | $814.4K |
| Mar 16, 2026 | Maria Claudia Borras
Officer
|
Sell | 60.6K | $3.3M |
| Mar 11, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Sell | 272.6K | $16.0M |
| Mar 11, 2026 | Maria Georgia Magno
Officer
|
Sell | 5.1K | $298.9K |
| Mar 11, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Option | 187.3K | $6.7M |
| Mar 6, 2026 | James E Apostolides
Officer
|
Grant | 23.7K | - |
| Mar 6, 2026 | Maria Claudia Borras
Officer
|
Grant | 100.0K | - |
| Mar 6, 2026 | Maria Georgia Magno
Officer
|
Grant | 10.7K | - |
| Mar 6, 2026 | Ahmed Farhan Moghal
Chief Financial Officer
|
Grant | 29.6K | - |
| Mar 6, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Grant | 459.8K | - |
| Mar 4, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Sell | 272.6K | $16.7M |
| Mar 4, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Option | 187.3K | $6.7M |
| Feb 24, 2026 | Ahmed Farhan Moghal
Chief Financial Officer
|
Grant | 8.0K | - |
| Feb 12, 2026 | Ahmed Farhan Moghal
Chief Financial Officer
|
Sell | 18.1K | $1.1M |
| Feb 10, 2026 | James E Apostolides
Officer
|
Sell | 25.8K | $1.5M |
| Feb 10, 2026 | James E Apostolides
Officer
|
Option | 11.0K | $252.5K |
| Feb 9, 2026 | Maria Claudia Borras
Officer
|
Sell | 54.4K | $3.2M |
| Feb 9, 2026 | Maria Georgia Magno
Officer
|
Sell | 19.2K | $1.1M |
| Feb 3, 2026 | William Geoffrey Beattie
Director
|
Sell | 18.0K | $1.0M |
| Feb 3, 2026 | Rebecca L Charlton
Officer
|
Sell | 2.8K | $158.2K |
| Feb 2, 2026 | James E Apostolides
Officer
|
Grant | 10.3K | - |
| Feb 2, 2026 | Maria Claudia Borras
Officer
|
Grant | 28.7K | - |
| Feb 2, 2026 | Rebecca L Charlton
Officer
|
Grant | 6.0K | - |
| Feb 2, 2026 | Maria Georgia Magno
Officer
|
Grant | 12.6K | - |
| Feb 2, 2026 | Ahmed Farhan Moghal
Chief Financial Officer
|
Grant | 7.5K | - |
| Feb 2, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Grant | 94.0K | - |
| Jan 30, 2026 | Amerino Gatti
Officer
|
Grant | 9.3K | - |
| Jan 26, 2026 | James E Apostolides
Officer
|
Grant | 3.9K | - |
| Jan 26, 2026 | Maria Claudia Borras
Officer
|
Grant | 16.6K | - |
| Jan 26, 2026 | Maria Georgia Magno
Officer
|
Grant | 2.7K | - |
| Jan 26, 2026 | Ahmed Farhan Moghal
Chief Financial Officer
|
Grant | 3.8K | - |
| Jan 26, 2026 | Lorenzo Simonelli
Chief Executive Officer
|
Grant | 50.9K | - |
| Dec 15, 2025 | Mohsen M Sohi
Director
|
Grant | 10.3K | - |
| Nov 13, 2025 | Rebecca L Charlton
Officer
|
Sell | 278 | $13.2K |
| Nov 12, 2025 | Rebecca L Charlton
Officer
|
Grant | 1.5K | - |
| Nov 10, 2025 | Ahmed Farhan Moghal
Chief Financial Officer
|
Grant | 5.1K | - |
| Sep 23, 2025 | Sreeganesh Ramaswamy
Officer
|
Sell | 25.0K | $1.3M |
| Sep 23, 2025 | James E Apostolides
Officer
|
Sell | 6.2K | $310.8K |
| Sep 23, 2025 | Rebecca L Charlton
Officer
|
Sell | 1.0K | $50.0K |
| Sep 23, 2025 | James E Apostolides
Officer
|
Option | 6.2K | $221.0K |
| Sep 10, 2025 | Maria Claudia Borras
Officer
|
Sell | 50.4K | $2.4M |
| Sep 10, 2025 | Maria Claudia Borras
Officer
|
Option | 50.4K | $1.9M |
| Sep 3, 2025 | Amerino Gatti
Officer
|
Grant | 9.8K | - |
| Jul 24, 2025 | Rebecca L Charlton
Officer
|
Sell | 500 | $22.5K |
| Jul 23, 2025 | Lorenzo Simonelli
Chief Executive Officer
|
Sell | 526.6K | $23.4M |
| Jul 23, 2025 | Lorenzo Simonelli
Chief Executive Officer
|
Option | 353.2K | $8.1M |
| Jun 17, 2025 | Maria Claudia Borras
Officer
|
Sell | 5.6K | $223.4K |
| Jun 17, 2025 | Maria Claudia Borras
Officer
|
Option | 5.6K | $128.3K |
| Jun 12, 2025 | Rebecca L Charlton
Officer
|
Sell | 6.0K | $232.4K |
| Jun 9, 2025 | Maria Claudia Borras
Officer
|
Sell | 54.3K | $2.1M |
| Jun 2, 2025 | Rebecca L Charlton
Officer
|
Grant | 11.7K | - |
| May 7, 2025 | James E Apostolides
Officer
|
Sell | 3.8K | $138.7K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.